Evidence map›Paper›PMID 23178497›Full record

ArticleOncogene2014

Coordinated regulation of XPA stability by ATR and HERC2 during nucleotide excision repair.

T-H Lee, J-M Park, S-H Leem, T-H Kang

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Targeting ATR in Cancer Medicine.Cancer treatment and research · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. ATR prevents CaFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  15. Novel loss-of-function mutation inJournal of medical genetics · 2021
    Article
  16. Review
  17. Review
  18. Article
  19. XPA: DNA Repair Protein of Significant Clinical Importance.International journal of molecular sciences · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

T-H LeeDepartment of Biological Science, Dong-A University, Busan, Republic of Korea.
J-M ParkDepartment of Biological Science, Dong-A University, Busan, Republic of Korea.
S-H LeemDepartment of Biological Science, Dong-A University, Busan, Republic of Korea.
T-H KangDepartment of Biological Science, Dong-A University, Busan, Republic of Korea.
Dong-A University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ATR (ATM and Rad3-related) is an essential regulator of the nucleotide excision repair (NER) mechanism. For NER activation, ATR phosphorylates XPA, the rate-limiting factor in the NER pathway. However, the role of XPA phosphorylation at serine 196 by ATR has been elusive. Here we show that ATR-mediated XPA phosphorylation enhances XPA stability by inhibiting HERC2-mediated ubiquitination and subsequent degradation. We analyzed stabilization of XPA with substitutions of Ser 196 either to aspartate (S196D), a phosphomimetic mutation, or to alanine (S196A), a phosphodeficient mutation. Upon ultraviolet damage, ATR facilitated HERC2 dissociation from the XPA complex to induce XPA stabilization. However, this regulation was abrogated in S196A-complemented XPA-deficient cells due to persistent association of HERC2 with this XPA complex, resulting in enhanced ubiquitination of S196A. Conversely, the S196D substitution showed delayed degradation kinetics compared with the wild-type and less binding with HERC2, resulting in reduced ubiquitination of S196D. We also found that XPA phosphorylation enhanced the chromatin retention of XPA, the interaction with its binding partners following DNA damage. Taken together, our study presents a novel control mechanism in the NER pathway by regulating the steady-state level of XPA through posttranslational modifications by which ATR-mediated phosphorylation induces XPA stabilization by antagonizing HERC2-catalyzed XPA ubiquitination.

Indexed as

DNA RepairAtaxia Telangiectasia Mutated ProteinsCell Line, TumorGene ExpressionGuanine Nucleotide Exchange FactorsHumansPhosphorylationProtein StabilityRNA, MessengerUbiquitinationUbiquitin-Protein LigasesXeroderma Pigmentosum Group A ProteinAtaxia Telangiectasia Mutated ProteinsATR protein, humanGuanine Nucleotide Exchange FactorsHERC2 protein, humanRNA, MessengerUbiquitin-Protein LigasesXeroderma Pigmentosum Group A ProteinXPA protein, human

Identifiers

PMID23178497
OpenAlexW2057834096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.